Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1073

    1.

    Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

    Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

    Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.

    Zheng L, Howell SJ, Hatala DA, Huang K, Kern TS.

    Diabetes. 2007 Feb;56(2):337-45. Erratum in: Diabetes. 2007 May;56(5):1486. PMID: 17259377 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Topical nepafenac inhibits ocular neovascularization.

    Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA.

    Invest Ophthalmol Vis Sci. 2003 Jan;44(1):409-15.PMID: 12506103 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

    Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT.

    Am J Pathol. 2008 May;172(5):1411-8. Epub 2008 Apr 10.PMID: 18403591 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.

    Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA, Kern TS.

    Diabetologia. 2007 Sep;50(9):1987-96. Epub 2007 Jun 22. Erratum in: Diabetologia. 2007 Oct;50(10):2228. PMID: 17583794 [PubMed - indexed for MEDLINE]Related articles

    6.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.

    Kowluru RA, Odenbach S.

    Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4161-6.PMID: 15505070 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.

    Gilbert RE, Kelly DJ, Cox AJ, Wilkinson-Berka JL, Rumble JR, Osicka T, Panagiotopoulos S, Lee V, Hendrich EC, Jerums G, Cooper ME.

    Diabetologia. 2000 Nov;43(11):1360-7.PMID: 11126403 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.

    Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW.

    Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5152-9.PMID: 17962468 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy.

    Zhang JZ, Xi X, Gao L, Kern TS.

    Curr Eye Res. 2007 Oct;32(10):883-9.PMID: 17963108 [PubMed - indexed for MEDLINE]Related articles

    11.

    Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.

    Ottlecz A, Bensaoula T.

    Invest Ophthalmol Vis Sci. 1996 Jul;37(8):1633-41.PMID: 8675407 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.

    Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP.

    Am J Pathol. 2002 Feb;160(2):501-9.PMID: 11839570 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

    Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.

    Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42.PMID: 18235022 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.

    Kowluru RA, Menon B, Gierhart DL.

    Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1645-51.PMID: 18385086 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats.

    Du Y, Sarthy VP, Kern TS.

    Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R735-41.PMID: 15371279 [PubMed - indexed for MEDLINE]Related articles

    17.

    Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients.

    Kowluru RA, Kanwar M, Chan PS, Zhang JP.

    Arch Ophthalmol. 2008 Sep;126(9):1266-72.PMID: 18779489 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.

    Lindstrom R, Kim T.

    Curr Med Res Opin. 2006 Feb;22(2):397-404. Review. Erratum in: Curr Med Res Opin. 2006 Jun;22(6):1237. PMID: 16466612 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hyperglycemia increases mitochondrial superoxide in retina and retinal cells.

    Du Y, Miller CM, Kern TS.

    Free Radic Biol Med. 2003 Dec 1;35(11):1491-9.PMID: 14642397 [PubMed - indexed for MEDLINE]Related articles